Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: A metaanalysis

Clinical Lung Cancer

Volumn 8, Issue 8, 2007, Pages 497-501

  Jiang, Lei ^a   Yang, Ke Hu ^a   Mi, Deng Hai ^b   Liu, Ya Li ^a   Tian, Jin Hui ^a   Ma, Bin ^a   Tan, Ji Ying ^a   Bai, Zheng Gang ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Anemia; Diarrhea; Leukopenia; Nausea; Neutropenia; Thrombocytopenia; Toxicity; Vomiting

Indexed keywords

CISPLATIN; ETOPOSIDE; IRINOTECAN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ANEMIA; ANOREXIA; ARTERIAL OXYGEN TENSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CANCER PATIENT; CANCER STAGING; CHOLINERGIC SYNDROME; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG SAFETY; DYSPNEA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; LEUKOPENIA; LIVER DISEASE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEUTROPENIA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

EID: 35348996153     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2007.n.035     Document Type: Article

References (19)

1. Available at: http://cancerweb.ncl.ac.uk/cgi-bin/omd?carcinomas. Accessed December 12, 1998.
2. Blanchon F, Grivaux M, Zureik M, et al. Cohort KBP-2000-CPHG: evaluation of factors influencing survival in lung cancer. Rev Mal Respir 2006; 23:165-171.
3. NCCN Clinical Practice Guidelines in Oncology™. Small Cell Lung Cancer. V.1.2007.MS-2.
4. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 9:33-64.
5. Canceranswers.com. Small cell lung cancer treatment information. Available at: http://www.canceranswers.com/Lung.Small.Cell.Cancer.html. Accessed March 20, 2007.
6. Hoffman PC, Maner M, Vokes EE. Lung cancer. Lancet 2000; 335:479-485.
7. Casciato D, Lowitz B, eds. Manual of Medical Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
8. Bai CX, Zhang X. Current treatment of lung cancer. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29:146.
9. Simon M, Argiris A, Murren JR. Progress in the therapy of small cell lung cancer. Crit Rev Oncol Hematol 2004; 49:119-133.
10. DeVita V, Hellman S, Rosemberg S, eds. Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia, PA: J.B. Lippincott & Company; 2000.
11. Jahan TM, Glassberg AB, Cornett P, et al. Small cell lung cancer. Available at: http://www.cancersupportivecare.com/smallcell.html. Accessed August 12, 2002.
12. Prasad US, Naylor AR, Walker WS, et al. Long term survival after pulmonary resection for small cell carcinoma of the lung. Thorax 1989; 44:784-787.
13. Johnson BE, Jänne PA. Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am 2004; 18:309-322.
14. Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000; 117(4 suppl 1):156S-162S.
15. Noda K, Nishiwaki Y, Kawahara M. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive disease small-cell lung cancer. N Engl Med 2002; 346:85-91.
16. Hanna N, Bunn PA Jr, Langer C. Randomized phase III comparing irinotecan/cisplatin with etoposide/cisplatin in patient with previously untreated extensive-staged disease small-cell lung cancer. J Clin Oncol 2006; 24:2038-2043.
17. Lara PN Jr, Gandara DR, Natale RB. Randomized phase III trial of irinotecan/cisplatin versus etoposide/cisplatin in patients with extensive-stage small-cell lung cancer. Clin Lung Cancer 2006; 7:353-356.
18. Segoro N, Noda K, Nishiwaki. A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511). Lung Cancer 2000; 29:30.
19. Pan D, Hou M, Li H. Irinotecan plus cisplatin compared with etoposide plus cisplatin for small cell lung cancer: a randomized clinical trial. Chin J Lung Cancer 2006; 5:443-445.